MRK Latest Headlines

Merck's Gardasil Shot Challenges To Continue, Analysts Optimistic For Newly Approved Sotatercept For Rare Lung Disease

at www.benzinga.com (Fri, 1-Nov 2:33 PM)

Merck & Company: Overcoming Challenges with Strategic Growth Prospects

at www.tipranks.com (Fri, 1-Nov 8:17 AM)

Merck & Company: Navigating One-Time Charges and Uncertainty in Gardasil Sales Amidst Strategic Shifts

at www.tipranks.com (Fri, 1-Nov 8:06 AM)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bristol-Myers Squibb (BMY), Abbott Laboratories (ABT) and Merck & Company (MRK)

at www.tipranks.com (Fri, 1-Nov 5:20 AM)

Merck & Co.: Hold Rating Amid Declining Gardasil Shipments and Inventory Challenges

at www.tipranks.com (Fri, 1-Nov 5:09 AM)

MRK Earnings: Merck Stock Drops Despite Q3 Beat

at www.tipranks.com (Fri, 1-Nov 4:16 AM)

Merck Reports Steady Q3 2024 Growth Amid Challenges

at www.tipranks.com (Fri, 1-Nov 12:36 AM)

Merck Beats Q3 Estimates, But Lowers Annual Forecast As Gardasil Vaccine Hit By Low China Demand

at www.benzinga.com (Thu, 31-Oct 10:15 AM)

5 stocks to watch on Thursday: AAPL, AMZN, PTON and more

at seekingalpha.com (Thu, 31-Oct 9:55 AM)

Options Volatility and Implied Earnings Moves Today, October 31, 2024

at www.tipranks.com (Thu, 31-Oct 8:05 AM)

Merck narrows outlook; Keytruda drives Q3 beat despite Gardasil impact

at seekingalpha.com (Thu, 31-Oct 7:03 AM)

Merck in charts: KEYTRUDA continues to show an upward trend past 3 years, rises ~17% in Q3

at seekingalpha.com (Thu, 31-Oct 6:42 AM)